The Group

Our research program focuses on cancer biology, in particular the role of angiogenesis and lymphangiogenesis towards tumor metastasis, as well as on the molecular control of chronic inflammation.

A major focus of the group is the genetic disposition for disease and for the response to specific therapies, with the aim to develop new individualized therapies for human diseases.